HAS Healthcare Advanced Synthesis SA acquires Cerbios-Pharma SA to create leading international Group in the CDMO sector, backed by 65 Equity Partners
Content not available.
Content not available.
Disclaimer: News content is aggregated from regulatory agencies and third-party publications. MedPath does not guarantee accuracy. This information is for reference only and does not constitute medical advice.